Novavax
NVAX
#5459
Rank
C$1.90 B
Marketcap
C$11.66
Share price
5.51%
Change (1 day)
31.10%
Change (1 year)

Novavax (NVAX) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : C$1.80 Billion

According to Novavax's latest financial reports the company's total liabilities are C$1.80 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novavax - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$1.78 B-43.01%
2024-12-31C$3.13 B-6.02%
2023-12-31C$3.33 B-15.04%
2022-12-31C$3.92 B5.18%
2021-12-31C$3.73 B206.4%
2020-12-31C$1.21 B159.8%
2019-12-31C$0.46 B-8.44%
2018-12-31C$0.51 B0.76%
2017-12-31C$0.50 B-5.42%
2016-12-31C$0.53 B314.86%
2015-12-31C$0.12 B140.62%
2014-12-31C$53.82 M58.56%
2013-12-31C$33.94 M54.44%
2012-12-31C$21.98 M69.79%
2011-12-31C$12.94 M-18%
2010-12-31C$15.78 M-4.14%
2009-12-31C$16.47 M-56.5%
2008-12-31C$37.85 M34.45%
2007-12-31C$28.15 M-13.24%
2006-12-31C$32.45 M-19.73%
2005-12-31C$40.43 M-24.71%
2004-12-31C$53.7 M-14.14%
2003-12-31C$62.54 M-19.89%
2002-12-31C$78.07 M23.69%
2001-12-31C$63.11 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
C$89.21 B 4,837.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$168.16 B 9,206.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$90.54 B 4,910.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$84.25 B 4,563.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
C$3.06 B 69.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$77.32 M-95.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$0.71 B-60.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
C$1.63 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C$0.87 B-51.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$1.21 B-32.64%๐Ÿ‡บ๐Ÿ‡ธ USA